Literature DB >> 23711288

Dearterialization with mucopexy versus haemorrhoidectomy for grade III or IV haemorrhoids: short-term results of a double-blind randomized controlled trial.

P I Denoya1, M Fakhoury, K Chang, J Fakhoury, R Bergamaschi.   

Abstract

AIM: There is scepticism regarding anatomical rationale and Doppler guidance for ligation of haemorrhoidal arteries. The null hypothesis of this randomized controlled trial (RCT) was that there is no difference in pain following dearterialization or haemorrhoidectomy for grade III/IV internal haemorrhoids in a minimum of three quadrants.
METHOD: This was a single-centre, double-blind RCT. Patients were allocated to dearterialization or haemorrhoidectomy. Included haemorrhoids were grade III, prolapsing but reducible; and grade IV, chronic non-incarcerated. The primary end-point was pain. Patients with external component, acute incarcerated grade IV or recurrent haemorrhoids were not included. The interventions were dearterialization (with Doppler guidance and mucopexy) or haemorrhoidectomy. The main outcome measure was the Brief Pain Inventory (BPI).
RESULTS: Twenty dearterialization patients were comparable to 20 haemorrhoidectomy patients for age (P = 0.107), body mass index (P = 0.559), race (P = 0.437), American Society of Anesthesiology score (P = 0.569), comorbidities (P = 0.592), grade (P = 0.096), quadrants (P = 0.222), Fecal Incontinence Quality-of-Life Score (FIQOL; P = 0.388), coping (P = 0.532), depression (P = 0.505), embarrassment (P = 0.842), and Short Form Health Survey (SF-12) physical components (P = 0.337), SF-12 mental components (P = 0.396) and constipation (P = 0.628) scores. Dearterialization patients had shorter operative time (36 vs 54 min, P = 0.043) with less pain (P = 0.011) and urinary retention (P = 0.012). Dearterialization patients had first bowel movement earlier (1.3 vs 4.6 days, P = 0.001), less pain (P = 0.011) and lower pain intensity (P = 0.001). Narcotic requirements were reduced in dearterialization patients (25% vs 100%, P = 0.001), with less medication (4.9 vs 112 pills, P = 0.001) and shorter regimen (0 vs 7 days, P = 0.001). BPI did not differ on days 1, 3, 5, 7 and 14 except for less pain in dearterialization patients. At 3 months, symptomatic relief was the same with no differences in BPI, FIQOL or SF-12.
CONCLUSION: Compared with haemorrhoidectomy, dearterialization led to less pain in grade III/IV haemorrhoids. Colorectal Disease
© 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Dearterialization; haemorrhoids; mucopexy; randomized controlled trial

Mesh:

Substances:

Year:  2013        PMID: 23711288     DOI: 10.1111/codi.12303

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  17 in total

Review 1.  Haemorrhoids.

Authors:  George E Reese; Alexander C von Roon; Paris P Tekkis
Journal:  BMJ Clin Evid       Date:  2009-01-29

2.  Tying up loose ends.

Authors:  K Yang; T M Connolly; R Bergamaschi
Journal:  Tech Coloproctol       Date:  2015-02-24       Impact factor: 3.781

Review 3.  Executive Summary - The Association of Colon & Rectal Surgeons of India (ACRSI) Practice Guidelines for the Management of Haemorrhoids-2016.

Authors:  Niranjan Agarwal; Kumkum Singh; Parvez Sheikh; Kushal Mittal; Varughese Mathai; Ashok Kumar
Journal:  Indian J Surg       Date:  2017-01-09       Impact factor: 0.656

Review 4.  Review of Hemorrhoid Disease: Presentation and Management.

Authors:  Zhifei Sun; John Migaly
Journal:  Clin Colon Rectal Surg       Date:  2016-03

5.  A prospective randomized trial of transanal hemorrhoidal dearterialization with mucopexy versus ultrasonic scalpel hemorrhoidectomy for grade III hemorrhoids.

Authors:  A Tsunoda; T Takahashi; H Kusanagi
Journal:  Tech Coloproctol       Date:  2017-09-04       Impact factor: 3.781

6.  Doppler-guided hemorrhoidal dearterialization with laser (HeLP): a prospective analysis of data from a multicenter trial.

Authors:  P Giamundo; A Braini; G Calabro'; N Crea; P De Nardi; F Fabiano; M Lippa; A Mastromarino; A M Tamburini
Journal:  Tech Coloproctol       Date:  2018-08-29       Impact factor: 3.781

7.  Hemorrhoid laser procedure with suture-pexy (HeLPexx): a novel effective procedure to treat hemorrhoidal disease.

Authors:  P Giamundo; M De Angelis; A Mereu
Journal:  Tech Coloproctol       Date:  2020-01-28       Impact factor: 3.781

8.  Distal Doppler-guided transanal hemorrhoidal dearterialization with mucopexy versus conventional hemorrhoidectomy for grade III and IV hemorrhoids: postoperative morbidity and long-term outcomes.

Authors:  L Trenti; S Biondo; A Galvez; A Bravo; J Cabrera; E Kreisler
Journal:  Tech Coloproctol       Date:  2017-04-27       Impact factor: 3.781

9.  Evaluation and management of hemorrhoids: Italian society of colorectal surgery (SICCR) consensus statement.

Authors:  M Trompetto; G Clerico; G F Cocorullo; P Giordano; F Marino; J Martellucci; G Milito; M Mistrangelo; C Ratto
Journal:  Tech Coloproctol       Date:  2015-09-24       Impact factor: 3.781

10.  Evaluation of transanal hemorrhoidal dearterialization: a single surgeon experience.

Authors:  G D LaBella; W P L Main; L R Hussain
Journal:  Tech Coloproctol       Date:  2015-01-31       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.